IDEAYA Biosciences (IDYA) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
IDEAYA Biosciences, Inc. has an agreement with Jefferies LLC for an at-the-market offering program, which allows the company to sell shares of its common stock at its discretion. The program could yield up to $350.0 million in gross proceeds. IDEAYA recently sold over 3 million shares, resulting in net proceeds of about $126.9 million, with a remaining $220.5 million worth of shares available for future sales under this program.
For further insights into IDYA stock, check out TipRanks’ Stock Analysis page.
